Compare SCYX & RAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCYX | RAVE |
|---|---|---|
| Founded | 1999 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.4M | 48.5M |
| IPO Year | 2014 | 1995 |
| Metric | SCYX | RAVE |
|---|---|---|
| Price | $3.76 | $3.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 78.7K | 42.4K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.36 | 11.76 |
| EPS | N/A | ★ 0.15 |
| Revenue | $257,000.00 | ★ $15,120,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $608.78 | N/A |
| P/E Ratio | ★ N/A | $20.87 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.57 | $2.25 |
| 52 Week High | $5.62 | $3.75 |
| Indicator | SCYX | RAVE |
|---|---|---|
| Relative Strength Index (RSI) | 43.82 | 47.43 |
| Support Level | $3.68 | $3.07 |
| Resistance Level | $5.10 | $3.48 |
| Average True Range (ATR) | 0.37 | 0.15 |
| MACD | -0.16 | -0.03 |
| Stochastic Oscillator | 3.18 | 25.30 |
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn Franchising and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The corporate administration and other segments. The Pizza Inn Franchising segment accounts for the majority of the company's revenue. Geographically, it generates the majority of the revenue from the United States.